Oncotarget: Predicting clinical outcomes using cancer progression associated signatures

(Impact Journals LLC) The P142 panel of metrics successfully predicted cancer progression status in patients with some, but not all cancer types analyzed.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news